Literature DB >> 28833652

Bateman purpura (dermatoporosis): a localized scurvy treated by topical vitamin C - double-blind randomized placebo-controlled clinical trial.

P Humbert1,2, F Fanian1, T Lihoreau1, A Jeudy1, G E Pierard3.   

Abstract

BACKGROUND: Bateman purpura is characterized by diffuse senile skin atrophy, senile purpura and spontaneous stellar pseudocicatrices. Cutaneous changes in the course of ageing have been related to lower levels of ascorbic acid into the dermis of elderly people.
OBJECTIVE: In this study, we postulate that senile purpura could be linked to dermal vitamin C deficiency and could be corrected by topical administration of this vitamin.
METHODS: A 12-weeks, hemi-member (forearm or leg), randomized double-blind comparative study was conducted in 18 patients with Bateman purpura aged over than 60 years. At each visit, clinical assessment and biometrological measurements were performed. Clinical examination and scoring by experts showed a significant improvement on the vitamin C-treated side compared with the control, with reduction of haemorrhage areas, increase of dermal thickness.
RESULTS: Twice-daily application of 5% topical vitamin C led to a clinically apparent improvement of the skin symptoms and allows beneficial effects on skin elasticity and thickness. Bateman purpura, a classical sign of photoaging whose origin has not clearly been recognized could be improved by vitamin C applied on to the skin.
CONCLUSION: These results confirm the hypothesis of the underlying role of vitamin C deficiency in the determinism of Bateman purpura.
© 2017 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28833652     DOI: 10.1111/jdv.14525

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  1 in total

Review 1.  Dermatoporosis - The Chronic Cutaneous Fragility Syndrome.

Authors:  Uwe Wollina; Torello Lotti; Aleksandra Vojvotic; Andreas Nowak
Journal:  Open Access Maced J Med Sci       Date:  2019-08-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.